Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug–Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling
Authors:
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (9) , 2727-2738
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 33 references indexed in Scilit:
- Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6CPT: Pharmacometrics & Systems Pharmacology, 2016
- Investigation of the Impact of Substrate Selection on In Vitro Organic Anion Transporting Polypeptide 1B1 Inhibition Profiles for the Prediction of Drug-Drug InteractionsDrug Metabolism and Disposition, 2015
- Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are InvolvedClinical Pharmacokinetics, 2014
- Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition I: Characterization of Basolateral Versus Biliary Clearance Using a Novel Protocol in Sandwich-Cultured HepatocytesThe Journal of Pharmacology and Experimental Therapeutics, 2013
- The Utility of Modeling and Simulation in Drug Development and Regulatory ReviewJournal of Pharmaceutical Sciences, 2013
- Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic EnzymesDrug Metabolism and Disposition, 2013
- Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte DataDrug Metabolism and Disposition, 2012
- Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and GemfibrozilThe Journal of Pharmacology and Experimental Therapeutics, 2004
- The effect of gemfibrozil on the pharmacokinetics of rosuvastatinClinical Pharmacology & Therapeutics, 2004
- Gemfibrozil greatly increases plasma concentrations of cerivastatinClinical Pharmacology & Therapeutics, 2002